- Morgan Stanley has launched coverage on Medidata (NASDAQ:MDSO) with an Overweight and $56 target.
- Shares of the cloud clinical data software provider are above $50 for the first time since April. They jumped in late July in response to a Q2 revenue beat and solid guidance.